Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a national provider of premium body contouring procedures, centered on its proprietary AirSculpt treatment. The company’s press releases and SEC filings provide regular updates on its operating performance, capital structure, leadership changes and strategic initiatives in the aesthetics and body contouring market.
On this news page, readers can follow AirSculpt’s quarterly earnings announcements, where the company reports case volumes, revenue trends, net income or loss, Adjusted EBITDA and liquidity metrics. These releases often include management commentary on transformation efforts, growth opportunities, margin improvement, debt reduction and the broader market context for aesthetics, including the impact of GLP‑1 use.
Investors can also track news related to AirSculpt’s capital markets activity, such as underwritten public offerings of common stock conducted under an effective shelf registration statement, and subsequent voluntary prepayments of term loan debt. The company has highlighted how these actions affect its capital structure, revolving credit facility availability and financial flexibility.
Governance and leadership developments are another key theme in AirSculpt news. Recent items include the appointment of a new Chief Financial Officer, the election of a Non-Executive Chairman of the Board, board and executive departures, and participation in investor conferences such as the Sidoti Micro Cap Conference. Each announcement is accompanied by context on the individual’s background or the company’s investor relations strategy.
By reviewing this curated stream of company-issued news, followers of AIRS stock can see how AirSculpt presents its business trajectory, risk considerations, non-GAAP metrics and strategic priorities over time. Bookmark this page to access the latest official updates, earnings dates, conference call details and other material disclosures from AirSculpt Technologies.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) announced its fourth quarter and full year 2022 results, highlighting significant growth in case volume and revenue.
Fourth quarter case volume increased by 15.7% year-over-year, reaching 3,337, while revenue rose by 8.4% to $40.7 million. For the full year, case volume grew 18.2% to 13,063 and revenue surged 26.6% to $168.8 million. Despite a diluted loss per share of $(0.26), the company reported an adjusted net income of $0.37 per share. Looking ahead, AirSculpt expects revenues between $187 million and $192 million for 2023, driven by the opening of five new centers.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) will report its fourth quarter 2022 financial results on March 10, 2023, before market open. A conference call is scheduled for 8:30 a.m. Eastern Time on the same day, accessible via phone or a live webcast on the company’s investor relations website. AirSculpt is a leading provider of body contouring procedures utilizing its proprietary AirSculpt® method, offering a premium consumer experience through minimally invasive fat removal. The company aims to deliver exceptional results to its patients, reflecting its commitment to quality care.
AirSculpt Technologies announces a leadership change with Todd Magazine appointed as the new CEO, effective at the end of January 2023. Dr. Aaron Rollins, the company's founder, moves to the role of Executive Chairman, focusing on strategic guidance. Magazine, with over 30 years of experience in retail and brand building, aims to leverage AirSculpt's proprietary technology to accelerate growth. The company maintains its full-year 2022 revenue guidance of $168-$170 million, indicating stable financial expectations moving forward.
AirSculpt® Technologies (NASDAQ: AIRS) is set to showcase the results of body contouring procedures performed on former Real Housewives stars Vicki Gunvalson and LeeAnne Locken via Instagram Live on December 15. The event will reveal their experiences documented through AirSculpt TV. Participants shared positive feedback about the quick recovery and transformative results from their AirSculpt treatments. With over 30,000 procedures performed, the company focuses on providing minimally invasive body contouring solutions through its Elite Body Sculpture brand.
AirSculpt Technologies (NASDAQ: AIRS) announces the opening of its first international Elite Body Sculpture location in London, set for the first half of 2023. This expansion aims to broaden its reach and enhance its premium body contouring services. The company plans to open a total of five new locations in 2023. Dr. Aaron Rollins, CEO, expressed enthusiasm for the London location, highlighting a luxury experience for clients, and welcomed Rana Das-Gupta as the new Medical Director, emphasizing his expertise in body fat reduction.
AirSculpt Technologies (NASDAQ: AIRS) announces the opening of its first international Elite Body Sculpture center in Toronto, Canada, marking a significant milestone in its global expansion. This new location offers AirSculpt's premium, minimally invasive body contouring procedures aimed at providing comfort and precision. The founder, Dr. Aaron Rollins, emphasized the rising demand for the proprietary AirSculpt method, promising Canadians enhanced body transformation experiences. For more information about the Toronto site and services, visit www.airsculpt.ca.
AirSculpt Technologies (NASDAQ:AIRS) reported a 12.2% revenue increase to $38.9 million for Q3 2022, driven by new center openings. However, a net loss of $7.4 million was recorded, impacted by increased equity compensation and public company expenses. Year-to-date revenue rose 33.8% to $128.1 million, with a case volume growth of 19.1%. Adjusted EBITDA decreased to $9.2 million, affected by rising costs. The Company lowered its 2022 revenue outlook to $168-170 million and adjusted EBITDA forecast to $45-47 million, while planning four new center openings.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) has announced a new credit agreement with lenders, securing $85 million in term loans and a $5 million revolving loan facility. This funding will pay off an existing $83.6 million credit facility due October 28, 2023. The new agreement, maturing on November 7, 2027, is expected to save the company approximately $2 million annually in cash interest, with no prepayment penalties. CFO Dennis Dean expressed satisfaction with the refinancing, noting it provides flexibility to pursue strategic growth plans.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) has announced the opening of its new centers in Philadelphia and Boston, bringing the total to 21 locations across the U.S. The company specializes in premium body contouring procedures utilizing its proprietary AirSculpt technology, known for its minimally invasive approach that facilitates faster healing and more precise results. Over 30,000 procedures have been conducted nationally, indicating a robust demand for their services. The Boston center opened in July, while the Philadelphia center is centrally located near King of Prussia Mall.
AirSculpt Technologies (NASDAQ: AIRS) has announced that it will release its third quarter results on November 10, 2022, after market close. Following this, a conference call will be held on November 11, 2022, at 8:30 AM ET for investors and the public to discuss the results. Access to the call is available via phone or through a webcast on the company's investor relations website. AirSculpt is known for its proprietary AirSculpt® method, which offers a minimally invasive body contouring procedure aiming to deliver significant results for patients.